Changing the face of dermatology landscape by leveraging global
opportunities
Program konference
- Day One, Thursday 3rd December,
2009
09:30 Registration and refreshments
10:00 Opening address from the chair
10:10 Current & emerging trends in the global dermatological market - Overview of the global dermatology market
- Regional differences in dermatology markets
- Major therapy areas and market segments by value and volume
- Recent trends in treatments and near term developments
- Pharma companies activities and interests in dermatology
John McDonald
Director Business Development
Astellas Pharma (Europe)
10:50 Is Psoriasis driving the dermatological market?
Dr Michael Tirant
Psoriasis Specialist
The Psoriasis and Skin Clinic (Australia)
11:30 Morning refreshments
11:50 Psoriasis and the biologics market - Psoriasis and biological drugs - an overview
- Market dynamics and key drivers
- Future opportunities and challenges
Dr Volker Koscielny
Medical Manager - Rheumatology/Dermatology
Wyeth
12.30 Androgen receptor antagonists for the topical suppression of sebum production - The early discovery strategy used to identify novel non-steroidal anti androgen compounds and the results from clinical studies on one compound
- An approach of reducing systemic effects by designing compounds for targeted follicular delivery
- An analysis of the chemical property space of
dermatologics
Lorna Mitchell
Medicinal Chemist
Pfizer
13:10 Networking lunch
14.10 Actinic Keratoses: new concepts, new treatments - Diagnosis and treatment
- Therapeutic algorithm for Actinic Keratoses (AK)
- Efficacy of Photodynamic Therapy treatment
Prof Torello Lotti
MD & Chair, Dermatology Dept., University of Florence
President, International Society of Dermatology
14:30 Skin examination and cancer screening - High-SPF sunscreens: are they effective in prevention?
- Skin examination and cancer screening
- Type, location, and extent of the lesions
- Surgical or chemical destruction of the lesions
Prof Jana Hercogová
President, Czech Academy of Dermatology
Chair, Communication Committee, EC International Society of Dermatology
15:10 Inflammatory Dermatoses - interlink between skin, brain and immune system - Psychiatric comorbidity in patients with immune and dermatological disorders
- The role of neuropeptides in the pathophysiology of inflammatory dermatoses
- Novel therapeutic approaches emerging from the field of
dermatopsychiatry
Dr Emilio Arbe
Senior Director - Clinical Research
Stiefel Laboratories
15:50 Afternoon refreshments
16:10 Understanding Dermatitis - Domination by systemic corticosteroids
- New formulations creating generic competition
- Long term treatments for contact dermatitis
Prof Georg Stingl
Department of Dermatology
Medical University of Vienna
16:50 Laser tissue regeneration and laser mediated pain relief - How low level laser therapy (LLLT) heals wounds and reduces pain
- Applications – Non-healing wounds, post operative inflammation and pain
- Evidence – LLLT clinical trials (RCTs) and comparisons with NSAIDs
- Demonstration (Video)
James Carroll
Founder & CEO
THOR Photomedicine
17:30 Closing remarks from the chair
17:35 Networking drinks
Take your discussions further and build new relationships in a relaxed and informal setting
Day Two, Friday 4th December, 2009
09:30 Registration and refreshments
10:00 Opening address from the chair
10:10 Trends in cosmetic development in EMEA - Trends in new formulations in cosmetics
- Impact of the new EU regulations on cosmetics development
- Natural versus chemical: what is the future?
Line Vivier
EMEA Franchise Manager
Stiefel Laboratories
10:50 Toxicology in consumer health care and dermatology business - Safety assessment in this ever changing regulatory world
- How to define the risk threshold in dermatology treatments
- Predictive toxicology in current dermatology new
treatments
Marc Princivalle
Head of Risk Assessment EMEA - Director of Toxicology
Stiefel Laboratories
11:30 Morning refreshments
11:50 Regulatory compliances for cosmetic dermatology - Shared regulation for Botox and dermal fillers
- Proposed deregulation to proportionate regulation for cosmetic class 3b/4 lasers/intense pulse lights
- GMP for cosmetic dermatology/treatments
Sally Taber
Director
Independent Healthcare Advisory Services
12:30 Evaluating technologies for cosmetic dermatology - Use of imaging systems to evaluate skin
- Imaging systems in clinical trials
- Claim support dilemmas
- Correlation of data
- Nematodes - how not to annoy advertising authorities and
consultants
Dr Theresa M. Callaghan
Independent Consultant – Dermatology
13:00 Networking lunch
14.00 Non-invasive skin care & active cosmetics - Role of skin care actives- moisturisation, photoprotection and anti-aging
- Non- invasive procedures (skin peels, microdermabrasion) in conjunction with skin care actives
- Understanding the market for active cosmetics in the developing
world
Harish Mahalingam
Associate Director, Global Medical Affairs
Novartis Consumer Health
14:30 Wound management in dermatology - Wound management of chronic wounds today – products and practice
- Current challenges
- Future changes in wound management
- What will drive the changes?
Bill Pigg
VP - Product Development & Quality
Systagenix
15:00 Fractional laser skin rejuvenation - Understanding fractional photothermolysis
- Discuss the availability of current fractional technologies
- Typical clinical outcomes
Speaker to be confirmed
Lynton Lasers
15:20 Hair disorders - Alopecia – unraveling predisposition to pattern hair loss
- New ingredients – new hope?
- Links between skin and hair – how can problems with your skin
affect your hair?
Gill Westgate
Commercial Manager, Centre for Skin Sciences, Bradford University
Director, Westgate Consultancy
15:50 Afternoon refreshments
16:10 Panel discussion: Cosmetic dermatology & medical ethics - Does it meet the ethical values?
- Challenges: safety and long-term efficacy of cosmetic surgery procedures
- How is it driving the consumer desire?
16.50 Case study: Future trends in dermatology towards 2015
Expert Rater Assisted Symptom Evaluation (ERASE): a novel web-based technique to confirm diagnosis and enhance signal detection in randomised, controlled trials
Joep Schoemaker
Senior Clinical Project Scientist
Schering Plough Research Institute
17:30 Chairs closing remarks
17:40 End of Conference
Kontakt: bijal.patel@vgpharma.com
Web: http://www.visionga...erence.aspx?cid=241
- Přidat do kalendáře: 2009-12-03 00:00:00 2009-12-04 23:59:59 Europe/Prague Dermatological Advances Changing the face of dermatology landscape by leveraging global opportunities BSG Conference Centre, London, UK
